These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35094774)

  • 1. Advances in microfluidic 3D cell culture for preclinical drug development.
    Russo M; Cejas CM; Pitingolo G
    Prog Mol Biol Transl Sci; 2022; 187(1):163-204. PubMed ID: 35094774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidic organ-on-chip system for multi-analyte monitoring of metabolites in 3D cell cultures.
    Dornhof J; Kieninger J; Muralidharan H; Maurer J; Urban GA; Weltin A
    Lab Chip; 2022 Jan; 22(2):225-239. PubMed ID: 34851349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cultivating human tissues and organs over lab-on-a-chip models: Recent progress and applications.
    Bhagat S; Singh S
    Prog Mol Biol Transl Sci; 2022; 187(1):205-240. PubMed ID: 35094775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct 3D printed biocompatible microfluidics: assessment of human mesenchymal stem cell differentiation and cytotoxic drug screening in a dynamic culture system.
    Riester O; Laufer S; Deigner HP
    J Nanobiotechnology; 2022 Dec; 20(1):540. PubMed ID: 36575530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances on Cell Culture Platforms for In Vitro Drug Screening and Cell Therapies: From Conventional to Microfluidic Strategies.
    Cardoso BD; Castanheira EMS; Lanceros-Méndez S; Cardoso VF
    Adv Healthc Mater; 2023 Jul; 12(18):e2202936. PubMed ID: 36898671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration.
    Wang H; Brown PC; Chow ECY; Ewart L; Ferguson SS; Fitzpatrick S; Freedman BS; Guo GL; Hedrich W; Heyward S; Hickman J; Isoherranen N; Li AP; Liu Q; Mumenthaler SM; Polli J; Proctor WR; Ribeiro A; Wang JY; Wange RL; Huang SM
    Clin Transl Sci; 2021 Sep; 14(5):1659-1680. PubMed ID: 33982436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D cell cultures toward quantitative high-throughput drug screening.
    Wang Y; Jeon H
    Trends Pharmacol Sci; 2022 Jul; 43(7):569-581. PubMed ID: 35504760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Cardiac Tissue for Advanced Heart-On-A-Chip Platforms.
    Chen X; Liu S; Han M; Long M; Li T; Hu L; Wang L; Huang W; Wu Y
    Adv Healthc Mater; 2024 Jan; 13(1):e2301338. PubMed ID: 37471526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From organ-on-chip to body-on-chip: The next generation of microfluidics platforms for in vitro drug efficacy and toxicity testing.
    Lacombe J; Soldevila M; Zenhausern F
    Prog Mol Biol Transl Sci; 2022; 187(1):41-91. PubMed ID: 35094781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: 3D cell models for organ-on-a-chip applications.
    Żuchowska A; Baranowska P; Flont M; Brzózka Z; Jastrzębska E
    Anal Chim Acta; 2024 May; 1301():342413. PubMed ID: 38553129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ-on-a-chip: A new tool for in vitro research.
    Yan J; Li Z; Guo J; Liu S; Guo J
    Biosens Bioelectron; 2022 Nov; 216():114626. PubMed ID: 35969963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomaterials and Microfluidics for Drug Discovery and Development.
    Carvalho MR; Truckenmuller R; Reis RL; Oliveira JM
    Adv Exp Med Biol; 2020; 1230():121-135. PubMed ID: 32285368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.
    Wang YI; Carmona C; Hickman JJ; Shuler ML
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29205920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ/body-on-a-chip based on microfluidic technology for drug discovery.
    Kimura H; Sakai Y; Fujii T
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):43-48. PubMed ID: 29175062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney-on-a-Chip: A New Technology for Predicting Drug Efficacy, Interactions, and Drug-induced Nephrotoxicity.
    Lee J; Kim S
    Curr Drug Metab; 2018; 19(7):577-583. PubMed ID: 29521220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascularization Strategies in 3D Cell Culture Models: From Scaffold-Free Models to 3D Bioprinting.
    Anthon SG; Valente KP
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ-on-a-chip platforms for studying drug delivery systems.
    Bhise NS; Ribas J; Manoharan V; Zhang YS; Polini A; Massa S; Dokmeci MR; Khademhosseini A
    J Control Release; 2014 Sep; 190():82-93. PubMed ID: 24818770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Organs-on-Chips: A Review of the State-of-the-Art, Current Prospects, and Future Challenges.
    Zarrintaj P; Saeb MR; Stadler FJ; Yazdi MK; Nezhad MN; Mohebbi S; Seidi F; Ganjali MR; Mozafari M
    Adv Biol (Weinh); 2022 Jan; 6(1):e2000526. PubMed ID: 34837667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfluidics for 3D Cell and Tissue Cultures: Microfabricative and Ethical Aspects Updates.
    Limongi T; Guzzi F; Parrotta E; Candeloro P; Scalise S; Lucchino V; Gentile F; Tirinato L; Coluccio ML; Torre B; Allione M; Marini M; Susa F; Fabrizio ED; Cuda G; Perozziello G
    Cells; 2022 May; 11(10):. PubMed ID: 35626736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.